Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2407
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody ; volume:20 ; number:1 ; day:14 ; month:7 ; year:2020 ; pages:1-8 ; date:12.2020
BMC cancer ; 20, Heft 1 (14.7.2020), 1-8, 12.2020

Creator
Matsuoka, Hiroshi
Hayashi, Takahiro
Takigami, Karen
Imaizumi, Kazuyoshi
Shiroki, Ryoichi
Ohmiya, Naoki
Sugiura, Kazumitsu
Kawada, Kenji
Sawaki, Akira
Maeda, Koutaro
Ando, Yousuke
Uyama, Ichiro
Contributor
SpringerLink (Online service)

DOI
10.1186/s12885-020-07142-3
URN
urn:nbn:de:101:1-2020091021540723376234
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Matsuoka, Hiroshi
  • Hayashi, Takahiro
  • Takigami, Karen
  • Imaizumi, Kazuyoshi
  • Shiroki, Ryoichi
  • Ohmiya, Naoki
  • Sugiura, Kazumitsu
  • Kawada, Kenji
  • Sawaki, Akira
  • Maeda, Koutaro
  • Ando, Yousuke
  • Uyama, Ichiro
  • SpringerLink (Online service)

Other Objects (12)

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer

Managing immune-related adverse events in oncology

Managing immune-related adverse events in oncology

Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab

Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab

Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?

Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?

Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events

Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events

Corticosteroid-resistant immune-related adverse events: a systematic review

Corticosteroid-resistant immune-related adverse events: a systematic review

Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis

Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis

Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors

Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors

Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates

Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates

Related objects